Compounds > 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
Page last updated: 2024-08-24

4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and Hormone-Dependent Neoplasms

4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachmann, H; Gust, R; Lubczyk, V1
Hillard, EA; Huché, M; Jaouen, G; Pigeon, P; Salomon, E; Top, S; Vessières, A1

Other Studies

2 other study(ies) available for 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol and Hormone-Dependent Neoplasms

ArticleYear
Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.
    Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8

    Topics: Animals; Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cattle; Cytosol; Drug Screening Assays, Antitumor; Estrogen Receptor Modulators; Ethylenes; Female; Humans; Neoplasms, Hormone-Dependent; Phenols; Radioligand Assay; Receptors, Estrogen; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured; Uterus

2003
Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
    Journal of medicinal chemistry, 2005, Apr-21, Volume: 48, Issue:8

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Electrochemistry; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Humans; Models, Molecular; Neoplasms, Hormone-Dependent; Organometallic Compounds; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Tamoxifen

2005